News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Snap launched self-contained SPECS AR glasses at $2,195 for pre-order, said shipments start this fall, and its shares rose over 3%.
  • Qualcomm took a minority stake in Inspecs and will collaborate to develop and scale connected smart-glasses manufacturing.
  • GM and Lockheed Martin announced a DoD-backed partnership to expand U.S. defense manufacturing capacity, focusing on production readiness and supply chains.
  • Pelthos director Todd C. Davis bought about 36,000 shares, lifting the stock roughly 5.7%.
  • ECB official Gabriel Makhlouf warned a US-Iran interim deal reopening the Strait of Hormuz may not quickly ease eurozone inflation.
  • Gildan defended its disclosures and reaffirmed fiscal 2026 guidance after a short-seller report, saying it will not comment further.
  • Guggenheim named Abivax its top biotech pick ahead of a late-June Phase III readout despite mixed safety and efficacy signals.

Latest Articles

Ligand Pharmaceuticals Director Jason Aryeh Offloads $1.25M in Shares Amid Valuation Concerns and Merger Activity

Ligand Pharmaceuticals Director Jason Aryeh Offloads $1.25M in Shares Amid Valuation Concerns and Merger Activity

Jason Aryeh, a director at Ligand Pharmaceuticals Inc (NASDAQ:LGND), executed a series of sales totaling 5,000 shares of common stock valued at approximately $1.25 million. The divestment occurred as the company's shares approached a 52-week high of $258.56, despite the stock appearing overvalued relative to its fair value according to recent analy…

Ligand Pharma Director John L. LaMattina Sells $1.15 Million in Stock

Ligand Pharma Director John L. LaMattina Sells $1.15 Million in Stock

John L. LaMattina, a director at Ligand Pharmaceuticals Inc. (NASDAQ:LGND), executed a significant sale of company shares on June 10, 2026, divesting a total of approximately $1,151,774 worth of common stock. The transaction involved the disposal of 4,591 shares across multiple price points, leaving Mr. LaMattina with a remaining direct holding of …

Mexico's S&P/BMV IPC Climbs as Industrials and Consumer Stocks Lead Gains

Mexico's S&P/BMV IPC Climbs as Industrials and Consumer Stocks Lead Gains

Mexico's stock market closed higher on Friday, with the S&P/BMV IPC rising 1.46%. Gains were concentrated in the Industrials, Consumer Goods & Services and Consumer Staples sectors. Market breadth favored advance across the exchange, though several individual names moved lower. Commodities and FX markets showed notable moves during the session.

Traws Pharma Provides Regulatory Update on Influenza Program

Traws Pharma Provides Regulatory Update on Influenza Program

Traws Pharma announced the deferment of its planned Phase 2a human influenza challenge study for its lead antiviral candidate, tivoxavir marboxil (TXM), due to a negative review by the UK's MHRA. Despite the setback, the company remains committed to advancing TXM and other back-up influenza antiviral compounds with improved profiles, highlighting t…

Heartland Express, Inc. Declares Regular Quarterly Dividend

Heartland Express, Inc. Declares Regular Quarterly Dividend

Heartland Express, Inc. announced the declaration of a regular quarterly cash dividend of $0.02 per share payable on July 6, 2026, marking the company's 92nd consecutive quarterly dividend payment. The total dividend payout is estimated at $1.6 million based on approximately 78 million shares outstanding, continuing a dividend program that began in…

North Korea Decries U.S. Approval of Advanced Missiles for South Korea, Says KCNA

North Korea Decries U.S. Approval of Advanced Missiles for South Korea, Says KCNA

North Korea's foreign ministry publicly denounced a recent U.S. decision to approve the sale of advanced air-to-air missiles and related equipment to South Korea, saying the move will exacerbate tensions on the Korean peninsula. The statement, carried by state media KCNA, said U.S.-South Korea military cooperation is being systematically strengthen…

Stardust Power Director Charlotte Nangolo Executes $17,400 Share Sale

Stardust Power Director Charlotte Nangolo Executes $17,400 Share Sale

Charlotte Nanguloshi Nangolo, a director at Stardust Power Inc. (NASDAQ:SDST), executed a sale of 10,000 shares on June 11, 2026, totaling $17,400 at $1.74 per share. Following the transaction, Nangolo retains direct ownership of 30,002 shares. The sale follows a 65% year-over-year decline in SDST stock, though current market data places the share …

Gen Digital Director Ondrej Vlcek Offloads $2.48M in Equity

Gen Digital Director Ondrej Vlcek Offloads $2.48M in Equity

Ondrej Vlcek, a director at Gen Digital Inc. (NASDAQ: GEN), executed a significant equity transaction on June 10, 2026, selling 100,000 shares of the company's common stock. The transaction, valued at $2,478,300, reflects a weighted average sale price of $24.783 per share. Despite this divestment, Vlcek retains substantial ownership, with direct ho…

Warby Parker Director Moon Youngme E Executes $265,300 Share Disposition Amid Strategic Product Launches

Warby Parker Director Moon Youngme E Executes $265,300 Share Disposition Amid Strategic Product Launches

Warby Parker Inc. (NASDAQ:WRBY) Director Moon Youngme E has completed the sale of 10,000 shares of the company's Class A Common Stock, with the transaction totaling $265,300. This disposal follows a period of significant stock price appreciation and coincides with the company's recent introduction of its first Intelligent Eyewear frame in partnersh…